Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEPOLIZUMAB Cause Injection site bruising? 125 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Injection site bruising have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.3% of all adverse event reports for MEPOLIZUMAB.

125
Reports of Injection site bruising with MEPOLIZUMAB
0.3%
of all MEPOLIZUMAB reports
3
Deaths
15
Hospitalizations

How Dangerous Is Injection site bruising From MEPOLIZUMAB?

Of the 125 reports, 3 (2.4%) resulted in death, 15 (12.0%) required hospitalization, and 2 (1.6%) were considered life-threatening.

Is Injection site bruising Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 125 reports have been filed with the FAERS database.

What Other Side Effects Does MEPOLIZUMAB Cause?

Asthma (11,033) Dyspnoea (9,192) Wheezing (6,093) Product dose omission issue (5,873) Cough (4,577) Pneumonia (4,107) Therapeutic product effect incomplete (4,106) Drug ineffective (3,880) Loss of personal independence in daily activities (3,566) Fatigue (2,656)

What Other Drugs Cause Injection site bruising?

ETANERCEPT (7,734) ADALIMUMAB (7,249) EVOLOCUMAB (4,409) TERIPARATIDE (4,405) DUPILUMAB (4,332) TIRZEPATIDE (2,665) SECUKINUMAB (1,969) DULAGLUTIDE (1,832) HUMIRA (1,623) EXENATIDE (1,299)

Which MEPOLIZUMAB Alternatives Have Lower Injection site bruising Risk?

MEPOLIZUMAB vs MEPROBAMATE MEPOLIZUMAB vs MERCAPTOPURINE MEPOLIZUMAB vs MEROPENEM MEPOLIZUMAB vs MEROPENEM ANHYDROUS MEPOLIZUMAB vs MESALAMINE

Related Pages

MEPOLIZUMAB Full Profile All Injection site bruising Reports All Drugs Causing Injection site bruising MEPOLIZUMAB Demographics